Cargando…
A six-metabolite panel as potential blood-based biomarkers for Parkinson’s disease
Characterisation and diagnosis of idiopathic Parkinson’s disease (iPD) is a current challenge that hampers both clinical assessment and clinical trial development with the potential inclusion of non-PD cases. Here, we used a targeted mass spectrometry approach to quantify 38 metabolites extracted fr...
Autores principales: | Klatt, Stephan, Doecke, James D., Roberts, Anne, Boughton, Berin A., Masters, Colin L., Horne, Malcolm, Roberts, Blaine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516864/ https://www.ncbi.nlm.nih.gov/pubmed/34650080 http://dx.doi.org/10.1038/s41531-021-00239-x |
Ejemplares similares
-
Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer’s disease
por: Laffoon, Scott B., et al.
Publicado: (2022) -
Rubidium and potassium levels are altered in Alzheimer’s disease brain and blood but not in cerebrospinal fluid
por: Roberts, Blaine R., et al.
Publicado: (2016) -
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
por: Pedrini, Steve, et al.
Publicado: (2017) -
Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study
por: Roberts, Blaine R., et al.
Publicado: (2023) -
Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer’s disease
por: Mukherjee, Soumya, et al.
Publicado: (2021)